Position in SANA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$130,629,006
+$22,829,790 QoQ
Shares Held
37,429,515
-0.0% QoQ
Ownership
12.5%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1
of 211 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SANA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FMR LLC holds $61,424,667,384 across 370 Biotechnology names. SANA ranks #82 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
5,231,452 | $4,853,584,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,023,962 | $4,522,663,276 | |
| 3 | MRNA |
Moderna, Inc.
|
51,859,891 | $3,631,748,165 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
81,020,390 | $2,867,311,601 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
12,200,422 | $2,284,895,029 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,631,956 | $1,953,067,789 | |
| 7 | INSM |
INSMED Inc
|
16,143,583 | $1,721,228,815 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,418,197 | $1,642,111,277 |
All Filings in SANA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $130,629,006 | 37,429,515 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $107,799,216 | 37,430,284 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $152,341,255 | 37,430,284 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $132,881,345 | 37,431,365 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $92,364,925 | 33,833,306 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $56,705,825 | 33,753,468 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $54,589,054 | 33,490,218 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $131,494,167 | 31,609,175 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $148,349,432 | 27,170,226 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $220,425,370 | 22,042,537 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $64,265,265 | 15,751,291 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $61,528,080 | 15,898,729 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $99,198,626 | 16,644,065 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $29,933,883 | 9,154,093 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $36,219,168 | 9,169,410 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $55,240,110 | 9,206,685 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $62,683,973 | 9,748,674 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $76,289,913 | 9,236,067 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $133,559,132 | 8,627,851 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $190,355,794 | 8,452,744 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $168,076,819 | 8,549,177 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $292,373,502 | 8,735,390 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||